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15 Abstract
16 AIM: To assess the biosafety of a poly(acrylamide-co-sodium acrylate) hydrogel as a 3D-printed 
17 intraocular lens (IOL) material.
18 METHODS: The biosafety of the poly(acrylamide-co-sodium acrylate) hydrogel was first 
19 analyzed in vitro using human lens epithelial cells (LECs) and the ARPE19 cell line, and a CCK-8 
20 assay was performed to investigate alterations in cell proliferation. A thin film of a 
21 poly(acrylamide-co-sodium acrylate) hydrogel and a conventional IOL were intraocularly 
22 implanted into the eyes of New Zealand white rabbits respectively, and a sham surgery served as 
23 control group. The anterior segment photographs, intraocular pressure (IOP), blood parameters 
24 and electroretinograms were recorded. Inflammatory cytokines in the aqueous humor, such as 
25 TNF and IL-8, were examined by ELISA. Cell apoptosis of the retina was investigated by 
26 TUNEL assay, and macrophage activation was detected by immunostaining. 
27 RESULTS: The poly(acrylamide-co-sodium acrylate) hydrogel did not slow cell proliferation 
28 when cocultured with human LECs or ARPE19 cells. The implantation of a thin film of a 
29 3D-printed IOL composed of the poly(acrylamide-co-sodium acrylate) hydrogel did not affect the 
30 IOP, blood parameters, electroretinogram or optical structure in any of the three experimental 
31 groups (n=3 for each group). Both TNF and IL-8 in the aqueous humor of the hydrogel group 
32 were transiently elevated 1 week post-operation and recovered to normal levels at 1 and 3 months 
33 post-operation. Iba1+ macrophages in the anterior chamber angle of the hydrogel group were 
34 increased markedly compared to those of the control group; however, there was no significant 
35 difference compared to those in the IOL group. 
36 CONCLUSION: The poly(acrylamide-co-sodium acrylate) hydrogel is a safe material for 3D 
37 printing of personal IOLs that hold great potential for future clinical applications.
38 KEYWORDS: Cataract; Biosafety; Lens Epithelial Cells; ARPE19 Cells; Intraocular Lens; 3D 
39 Printing; Poly Hydrogel; Rabbit
40
41 INTRODUCTION
42 More than 95 million people worldwide have cataracts, which is the leading cause of blindness.1 
43 Phacoemulsification combined with intraocular lens (IOL) implantation is the most effective way 
44 to treat cataract so far.2 However, the mass-produced model IOL based on a high-precision 
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45 machine tool fails to meet the growing demands of personalized customization of the human lens, 
46 and it is hard to obtain the best postoperative vision.3 Precision medicine is an inevitable trend in 
47 the development of clinical medicine, personalized customization is an extremely important 
48 component of precision medicine, and personalized IOL customization is an important means to 
49 improve the outcome of cataract surgery.
50 3D printing holds great potential in biomedical engineering research as well as in 
51 ophthalmologic applications,4-6 which enables cost-effective products and instruments that aid in 
52 therapeutic devices, such as IOLs, built specifically for individual cataract patients.7 Based on the 
53 clinical data, it is possible for us to design a personalized IOL suitable for the size of the lens 
54 capsule by digital optical modeling, simulating the quality of IOL imaging and correcting the 
55 wave front aberration.8 Achievement of 3D printing of IOLs is a great challenge, and the 
56 breakthrough bottleneck lies in the following points: 1) the fabrication of ultrahigh-precision 
57 roughness of the IOL surface (micro/nano-precision);9 2) the high transparency and UV-blocking 
58 ability of materials; 3) the flexibility, water richness and micromechanical characteristics of the 
59 organic materials; and 4) the biosafety of the material for 3D-printed IOLs.10,11 
60 Additive manufacturing and 3D printing create new approaches for the design and 
61 manufacturing of implants, such as microstructured eye implants, including multifocal diffractive 
62 aspheric IOL.12 We planned to print the IOL mold with a new responsive 
63 poly(acrylamide-co-sodium acrylate) hydrogel with 3D precise printing technology, which aims to 
64 provide accurate and personalized IOL products for cataract patients. The gel is a fully diluted 
65 crosslinking system that has no fluidity in the stable state. The main component of the gel is liquid 
66 by weight. However, due to the 3D crosslinking network, the structural integrity of the hydrogel 
67 network will not be dissolved due to the high hydrophilicity. Hydrogels are highly absorbent and 
68 light permeable (containing more than 90% water). Due to its high water content, the hydrogel 
69 also has a very similar flexibility to natural tissue, which makes it an ideal 3D printing material for 
70 making personalized IOLs. However, as responsive smart materials, hydrogels can encapsulate 
71 chemical compounds such as glucose, which are released by the stimulation of external factors, 
72 such as changes in pH. Thus, whether a poly(acrylamide-co-sodium acrylate) hydrogel is toxic to 
73 ocular tissue needs to be deliberately considered. Nevertheless, the issue of the biosafety of 
74 poly(acrylamide-co-sodium acrylate) hydrogels is unclear so far.
75 Here, we utilized a poly(acrylamide-co-sodium acrylate) hydrogel to create a thin film in order to 
76 investigate its biosafety after intraocular implantation. It was demonstrated in vivo that IOP, ERGs 
77 and inflammatory factors in the aqueous humor exhibited no significant difference after 
78 poly(acrylamide-co-sodium acrylate) hydrogel implantation. Moreover, similar results could be 
79 verified by experiments in vitro. Taken together, the results indicate that the 
80 poly(acrylamide-co-sodium acrylate) hydrogel does not harm the rabbit ocular tissue and causes 
81 no inflammation in vitro or in vivo, supporting the idea that it is a safe material for on-demand 
82 manufacturing of patient-personalized IOLs.
83 MATERIALS AND METHODS
84 Laboratory Animal Welfare
85 All experiments were performed on New Zealand white rabbits provided by the Experimental 
86 Animal Centre of Southwest Hospital, Army Medical University. The New Zealand white rabbits 
87 were all raised in the Animal Care Centre of the Army Medical University and maintained with 
88 free access to water and food under a 12-h light/dark cycle. All animal experimental procedures 
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89 were formally approved by the Institutional Review Board of the Army Medical University.
90
91 Preparation of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Thin Film
92 The hydrogel solution was prepared according to the following formula: 17.5% 
93 N-isopropylacrylamide; 12.5% sodium acrylate; 1.5% N,N’-methylenebisacrylamide; 
94 N,N,N’,N’-tetramethylethylenediamine; 10% ammonium persulfate, H20. The solution was added 
95 to one of the molds and immediately joined with another mold. Then, the two pieces of mold were 
96 clamped together. After 30~60 minutes, after the gel was solidified, and the two molds were 
97 removed. The formed hydrogel crystals were transferred to phosphate buffered saline (PBS) for 
98 preservation.
99
100 Intraocular Implantation of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Thin Film 
101 into New Zealand White Rabbit Eyes
102 The New Zealand white rabbits were divided into three groups based on implants: the 
103 poly(acrylamide-co-sodium acrylate) hydrogel thin film as the hydrogel group, the conventional 
104 IOL as the IOL group, and the sham surgery as the control group (n=3 for each group). Animals 
105 were anesthetized with 3% pentobarbital sodium 1 ml/kg through the ear-rim auricular vein; the 
106 left eye was selected as the operative eye. Before the operation, tropicamide eye drops (Santen) 
107 were used for mydriasis. The eyelid was opened with an eye speculum, and the conjunctival sac 
108 was soaked with 5% povidone iodine for 90 seconds and then rinsed with saline. A 3.0 mm width 
109 transparent corneal incision was made at the 12 o’clock position, a 1.0 mm width auxiliary corneal 
110 incision was made at the 9 o’clock position, and sodium hyaluronate (SINGCLEAN) was injected 
111 into the anterior chamber. For the control group, the incision was sutured directly with 10-0 
112 polypropylene. For the hydrogel group and IOL group, we performed capsulorhexis, water 
113 separation, and phacoemulsification of the lens nucleus (Laureate, Alcon, USA), cleared the lens 
114 cortex with I/A, and injected the poly(acrylamide-co-sodium acrylate) hydrogel thin film (5 mm×5 
115 mm) or IOL (860 UV, acrylic intraocular lenses as a positive control of biosafety). The 12 o’clock 
116 incision was sutured with 10-0 nylon suture, balanced salt solution (BSS) was injected to form the 
117 anterior chamber capacity, and tobramycin dexamethasone eye ointment (Alcon, USA) was 
118 applied to the eyes after the operation. Intraocular pressures (IOP) was measured by a noncontact 
119 tonometer at 1 day, 1 week, 1 month, and 3 months post-operation.
120
121 Euthanasia and Histopathology
122 Three months after implantation, the New Zealand white rabbits were euthanized with 
123 pentobarbital sodium (400 mg/kg) administered intravenously. Afterwards, each eye containing 
124 the implant was taken from each rabbit for histological examination. Specimens were fixed in 4% 
125 paraformaldehyde for at least 24 hours and dehydrated in 30% sucrose for at least 24 hours, 
126 followed by embedding with Tissue-Tek O.C.T. Compound (Sakura Finetek USA, Inc., Torrance, 
127 CA 90501, USA). All tissue pieces were cut into 2–4 μm thick tissue sections (Leica CM1900UV 
128 cryostat). Then, all sections were routinely stained with hematoxylin-eosin (HE) and examined 
129 under a light microscope (OLYMPUS DP71; Olympus Europa SE & Co. KG, Hamburg, 
130 Germany) to assess fibroblast proliferation and anatomical abnormalities.
131
132 Cell Culture
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133 Human lens epithelial cells (LECs) were expanded from lens explants, which were provided by 
134 the Southwest Hospital Eye Bank. Briefly, the lens was washed in cold PBS containing 50 U mL-1 
135 penicillin and 100 μg mL-1 streptomycin, cut into 5 mm×5 mm small pieces and seeded onto 
136 human vitronectin (Gibco, Thermo Fisher, USA) precoated plates, and the explants were left for 
137 attachment. The second day, LECs were cultured in conditioned medium consisting of 
138 DMEM/F12 (HyClone), 10% FBS (Gibco), insulin-transferrin sodium selenite (1 μg mL-1, Gibco), 
139 penicillin (100 U mL-1) and streptomycin (100 μg mL-1, HyClone). As cells reached 
140 subconfluence, they were gently passaged at 1:6 to expand. The ARPE19 cell line was cultured 
141 according to the same procedures and conditions described above. The cells were co-cultured with 
142 the poly(acrylamide-co-sodium acrylate) hydrogel thin film (5 mm×5 mm) or PBS as control.
143
144 Immunostaining to Identify LECs
145 Immunostaining was routinely performed as previously described.13 Sections were incubated 
146 for 15 minutes with PBS, and sections were further incubated with PBS containing 0.1% (vol/vol) 
147 Triton X-100 for 15 minutes and further blocked with 1% (wt/vol) bovine serum albumin (BSA) 
148 in PBS at room temperature. The following primary antibodies were incubated at 4℃ overnight: 
149 Pax6 (1:500, Abcam), Sox2 (1:400, Abcam), αA-crystallin (1:200, Santa Cruz), α-SMA (1:400, 
150 Abcam), and Iba1 (1:500, Wako).
151
152 TUNEL Staining to Analyze the Apoptotic Cells and Immuno Cells in the Eyes Of Rabbits
153 Using the TUNEL Assay Kit (Abcam) as previously described14, the secondary antibodies 
154 included the goat anti-mouse Alexa Fluor 488 and goat anti-mouse Alexa Fluor 594 (Invitrogen). 
155 DAPI (1:10, Beyotime) was incubated for 8-10 minutes at 20℃ to counterstain nuclei, followed 
156 by cover-slipping with antifade mounting medium (Beyotime).
157
158 CCK-8 Assay to Analyze the Proliferation of LECs and APRE19 Cells
159 The cytotoxicity of the poly(acrylamide-co-sodium acrylate) hydrogel was measured using the 
160 Cell Counting Kit-8 (CCK-8) assay according to a previously published protocol.15 Absorbance at 
161 wavelengths of 450 and 650 nm was collected using a microplate reader (Varioskan Flash, 
162 Thermo Fisher, USA).
163
164 ELISA Assay to Analyze Cytokines
165 The aqueous humor was extracted with a 30G sterile needle syringe at the 9 o’clock position of 
166 the limbus at 1 week, 1 month, and 3 months post-operation. ELISAs to detect IL-8 and TNF 
167 (cloud-clone corp.) were performed as previously reported.16 The absorbance of each well was 
168 read at 450 nm and 550 nm. The 550 nm values were subtracted from the 450 nm values to correct 
169 for optical imperfections in the microplate. 
170
171 Electroretinogram Recording to Assess The Visual Function of Rabbits
172 Scotopic flash electroretinogram recording was performed at 3 months post-operation as 
173 described previously.17 Briefly, after 12-h dark adaptation, the rabbits were carefully anesthetized 
174 with 3% pentobarbital sodium (1 ml/kg). The pupils were dilated with 1% tropicamide. The body 
175 temperature was maintained at 37 °C with a heating pad to prevent hypothermia. Active gold 
176 electrodes were placed onto cornea serving as the recording electrodes. The reference and ground 
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177 electrodes were placed subcutaneously in the mid-frontal areas of the head and back, respectively. 
178 We performed light stimulation at densities of −2.5, −0.5, −0.02, and 0.5 log (cd*s/m2) for New 
179 Zealand white rabbits and 0.5 log (cd*s/m2) for rabbits. The amplitudes and peak times of the 
180 a-waves and b-waves were recorded and processed through a RETI-Port device (Roland Consult). 
181 All experimental procedures were performed in a dark room under dim red safety light. 
182
183 Microscopy, Image Acquisition, And Processing
184 All confocal images were collected by a Zeiss LSM880. Immunostaining data were all 
185 processed in ImageJ and Illustrator (Adobe).
186
187 Statistical Analysis
188 Data are shown as the means ± S.D. All statistical tests were performed by PRISM (GraphPad). 
189 Statistical significance was detected by Student’s t test (parametric). A P-value <0.05 was 
190 considered statistically significant. 
191
192 RESULTS
193 Synthesis of the Poly(acrylamide-co-sodium acrylate) Hydrogel
194 The new responsive poly(acrylamide-co-sodium acrylate) hydrogel was made from our 
195 modified formula as described in the materials and methods section. To produce patterned 
196 morphology and structure, a precise 3D-printed IOL mold was injected into the new responsive 
197 poly(acrylamide-co-sodium acrylate) hydrogel (Figure 1A). To better adapt for implantation into 
198 rabbit eyes, a thin film-like poly(acrylamide-co-sodium acrylate) hydrogel was made (Figure 1B). 
199 As a fresh hydrogel often remains unstable and releases small molecular chemical compounds 
200 such as glucose, to achieve a stable state of the poly(acrylamide-co-sodium acrylate) hydrogel, we 
201 pretreated the hydrogel with PBS and examined its optimal condition to reduce the influence on 
202 LECs. We found that after 9 days of pretreatment with PBS, the poly(acrylamide-co-sodium 
203 acrylate) hydrogel did not affect the survival or proliferation of LECs (Figure 1C, D).
204
205
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206 Figure 1 Synthesis of the poly(acrylamide-co-sodium acrylate) hydrogel thin film
207 A: A precise 3D-printed IOL mold was injected into the new responsive poly(acrylamide-co-sodium acrylate) 
208 hydrogel to produce a patterned morphology and structure; B: Image of the poly(acrylamide-co-sodium acrylate) 
209 hydrogel thin film; C: Trypan blue staining of LECs co-cocultured with the poly(acrylamide-co-sodium acrylate) 
210 hydrogel at 0, 3, 6, and 9 days of the PBS wash; D: CCK8 assay of LECs co-cocultured with the 
211 poly(acrylamide-co-sodium acrylate) hydrogel at 0, 3, 6, and 9 days of the PBS wash; Data are shown as the 
212 mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p < 0.005
213
214 Effect of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel on LECs and ARPE19 Cells 
215 in Vitro
216 To investigate whether the poly(acrylamide-co-sodium acrylate) hydrogel disturbs cell viability, 
217 we cocultured the poly(acrylamide-co-sodium acrylate) hydrogel with LECs and ARPE19 cells. 
218 The cultured cells positively expressed LEC markers, such as PAX6 and SOX2, and synthesized 
219 the specific -A crystallin and negatively expressed the fibroblast cell marker -SMA, which 
220 identified the LECs (Figure 2A~F). When LECs were cocultured with the 
221 poly(acrylamide-co-sodium acrylate) hydrogel, cell apoptosis emerged only at the adjacent area 




226 Figure 2 Coculture of poly(acrylamide-co-sodium acrylate) hydrogel thin films with LECs or ARPE19 cells 
227 A~F: Immunostaining of LECs showed that LECs were positively stained for the lens epithelial cell markers 
228 PAX6 (A, B), SOX2 (C), and α-A crystallin (D, E) and negatively stained for the fibroblast cell marker α-SMA 
229 (F); D~H: Bright field images of LECs co-cultured with (H) or without (G) the poly(acrylamide-co-sodium 
230 acrylate) hydrogel. Cells adjacent to the hydrogel were unable to attach to the matrix and ultimately underwent 
231 apoptosis (red arrow); I~J: Bright field images of ARPE19 cells co-cultured with the poly(acrylamide-co-sodium 
232 acrylate) hydrogel (I). The magnified image (J, white dashed area in I) shows that a minority of adjacent cells 
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233 underwent cell apoptosis (red arrow), whereas the distal cells stayed in a normal proliferative state. Scale bar, 50 
234 μm (A~F), 100 μm (G~J).
235
236 Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel into The Anterior 
237 Chamber of New Zealand White Rabbits Does Not Induce Endophthalmitis
238    To further evaluate the biosafety of poly(acrylamide-co-sodium acrylate) hydrogels, we 
239 performed intraocular implantation in New Zealand white rabbits. Slit-lamp imaging at 1 week 
240 post-operation indicated corrected location of the hydrogel at the anterior chamber (Figure 3A~C). 
241 No significant corneal opacification, keratic precipitate, hypopyon, or synechia was observed at 1 
242 month post-operation among all the groups (Figure 3D~F). Moreover, no anatomic abnormalities 
243 were observed at 3 months post-operation among all the groups (Figure 3G~I). In addition, the 
244 alteration of IOP after hydrogel implantation was not statistically significant (Figure 4A). To 
245 further investigate the effect of poly(acrylamide-co-sodium acrylate) hydrogel implantation on the 
246 intraocular inflammatory reaction, we performed ELISA to examine the key inflammatory factors 
247 IL-8 and TNF-α. ELISA of the aqueous humor showed that IL-8 (Figure 4B) and TNA- (Figure 
248 4C) of both the hydrogel and IOL groups were elevated at the first week post-operation, but that of 
249 the hydrogel group stayed consistent with that of the control group at 1 month and 3 months 
250 post-operation. In sum, implantation of the poly(acrylamide-co-sodium acrylate) hydrogel did not 
251 induce any endophthalmitis in the New Zealand white rabbit eyes. 
252
253
254 Figure 3 Implantation of poly(acrylamide-co-sodium acrylate) hydrogel thin film into the anterior chamber 
255 of New Zealand white rabbits does not induce endophthalmitis
256 A~C: Slit lamp images of the control group (A), hydrogel group (B) and IOL group (C) at 1 week post-operation 
257 showed successful implantation and correct location of the implants; D~F: Slit lamp images of the control group 
258 (D), hydrogel group (E) and IOL group (F) at 1 month post-operation showed no significant corneal opacification, 
259 keratic precipitate or endophthalmitis; G~I: Slit lamp images of the control group (G), hydrogel group (H) and IOL 
Page 7 of 35
www.ijo.cn





























































260 group (I) at 3 months post-operation showed no significant corneal opacification, keratic precipitate or 




265 Figure 4 Effects of poly(acrylamide-co-sodium acrylate) hydrogel implantation on the IOP and 
266 inflammatory factors in the aqueous humor
267 A: The IOP recordings revealed showed no significant differences among the control, hydrogel and IOL groups; 
268 B~C: ELISA of inflammatory factors such as IL-8 (B) and TNF-α (C) in the aqueous humor of the control, 
269 hydrogel and IOL groups; Data are shown as the mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p 
270 < 0.005; n.s. no significance.
271
272 Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Does Not Impair Visual 
273 Function 
274    Visual function may be well reflected by visual electrophysiology examinations, such as 
275 electroretinography (ERG). To further investigate the effect of poly(acrylamide-co-sodium 
276 acrylate) hydrogel implantation on visual function, we conducted flash-ERG examinations of the 
277 control, hydrogel, and IOL groups. The amplitude of the a-wave of rod, cone and combined 
278 rod-cone (Max) ERG 3 months after hydrogel implantation was not significantly altered, nor was 
279 the peak time of the wave (Figure 5A, B). Similarly, both the amplitude and peak time of the 
280 b-wave of rod, cone and combined rod-cone (Max) ERG 3 months after hydrogel implantation 
281 were also not significantly altered (Figure 5C, D). These results indicated normal function of 
282 photoreceptor cells and bipolar cells in the hydrogel groups 3 months post-operation. Moreover, 
283 we analyzed the characteristics of the Ops wave and light-adapted 30 Hz flicker. Consistent with 
284 the results above, the implantation of hydrogel did not affect the amplitude of the Ops wave and 
285 light-adapted 30 Hz flicker, as well as its peak time (Figure 5E~G), indicating an intact and 
286 well-functioning inner retina and cone system.
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288 Figure 5 Flash-ERGs of New Zealand white rabbits at 3 months post-implantation
289 A~B: Statistical analysis of the amplitudes (A) and peak time (B) of fERG a-waves at 0.5 log(cd*s/m2) in the three 
290 groups at 3 months post-operation; C~D: Statistical analysis of the amplitudes (C) and peak time (D) of fERG 
291 b-waves at 0.5 log(cd*s/m2) in the three groups at 3 months post-operation; E~G: Statistical analysis of the Ops 
292 wave amplitude (E) at 3.0 log (cd*s/m2) in the three groups at 3 months post-operation; F~G: Statistical analysis of 
293 the light-adapted 30 Hz flicker amplitude (F) and peak time (G) at 3.0 log(cd*s/m2) in the three groups at 3 months 
294 post-operation; Data are shown as the mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p < 0.005; 
295 n.s. no significance.
296 Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Does Not Damage Ocular 
297 Histology
298    Novel biomaterials are often toxic to the ocular tissue and cause severe abnormalities in 
299 histology. To evaluate the effect of poly(acrylamide-co-sodium acrylate) hydrogel implantation on 
300 the ocular histology, we first performed HE staining of New Zealand White Rabbit eyes after 3 
301 months of surgery. This result indicated that the hydrogel group maintained its normal histological 
302 characteristics, such as cell connections and layered lamination, as well as did the IOL group, all 
303 compared with the control group (Figure 6A, B, C). The TUNEL assay revealed that no cellular 
304 apoptosis emerged at the cornea, anterior chamber angle (ACA), or retina in any of the three 
305 groups, confirming the nontoxic character of the poly(acrylamide-co-sodium acrylate) hydrogel 
306 (Figure 7J~R). Moreover, IBA1+ macrophage cells did not accumulate in the cornea or retina 
307 except for the ACA in the hydrogel and IOL groups 3 months post-implantation (Figure 7A~I). 
308 The recruitment of macrophages at the ACA may represent the immune response caused by the 
309 hydrogel or IOL implants, which triggered the phagocytic activation of macrophages.
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311 Figure 6 The poly(acrylamide-co-sodium acrylate) hydrogel does not cause histological alteration 3 months 
312 post-implantation
313 A: HE staining of New Zealand White Rabbit eyes showed the detailed histological identity of the cornea, anterior 
314 chamber angle, and retina in the control group; B: HE staining of New Zealand White Rabbit eyes showed the 
315 detailed histological identity of the cornea, anterior chamber angle, and retina in the hydrogel group. The cell 
316 connectivity and layered lamination were normal compared with those of the control group, even though the 
317 cornea was ruptured due to the limitations of the HE staining procedure; C: HE staining of New Zealand White 
318 Rabbit eyes showed the detailed histological identity of the cornea, anterior chamber angle, and retina in the IOL 
319 group. Scale bar, 100 μm.
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321 Figure 7 Macrophage activation and cell apoptosis of New Zealand white rabbit eyes 3 months after 
322 poly(acrylamide-co-sodium acrylate) hydrogel implantation
323 A~I: Immunostaining of Iba1 in New Zealand white rabbit eyes at 3 months post-implantation showed Iba1+ 
324 macrophage augmentation at the cornea (A~C), ACA (D~F) and retina (G~I) in the control group (A, D, G), the 
325 hydrogel group (G, E, H), and the IOL group (C,F,I); J~R: TUNEL assay of New Zealand White Rabbit eyes at 3 
326 months post-implantation showed TUNEL+ apoptotic cell accumulation at the cornea (J~L), ACA (M~O) and 
327 retina (P~R) in the control group (J, M, P), the hydrogel group (K, N, Q), and the IOL group (L, O, R); S: 
328 Statistical analysis of Iba+ macrophages in the cornea, ANA, and retina in all three groups. Scale bar, 100 μm. 




333 The eye exerts a unique ocular morphology, and all ocular organic architectures are susceptible 
334 to a number of diseases that may require treatment via different modalities, such as sustained drug 
335 delivery and artificial biotissue substitution.18 In the past century, hydrogels have been used in 
336 various applications as effective materials. The unique network structure of a hydrogel makes it 
337 highly hydrophilic and biocompatible, and it exhibits soft physical properties similarly to living 
338 tissue, which makes it an ideal and potential biomaterial for ophthalmic applications such as 
339 intraocular pumps, injections and implants, reducing comorbidities caused by glaucoma, cataracts, 
340 and diabetic retinopathies.19 3D printing allows the creation of objects with complex 
341 three-dimensional geometries and photologies from a computer-aided design and printed 
342 biomaterials to tissue analog structures without any change in their mechanical or biological 
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343 properties.20,21 However, given the nature of the polymers in hydrogel formulations and the 
344 materials used in the preparation of ophthalmic gels, it is paramount that any new hydrogel 
345 formulation intended for ocular application should be inevitably investigated for potential 
346 toxicity/adverse effects on ocular tissues. In this report, we generated a 
347 poly(acrylamide-co-sodium acrylate) hydrogel as a thin film and found that the newly formed 
348 hydrogel needs 9 days of pretreatment with PBS to stabilize its structure, reflecting the 
349 stimuli-controlled phase transition and small molecule release characteristics of 
350 stimulus-responsive hydrogels22. Second, we performed coculture experiments in vitro and 
351 implantation experiments in vivo to assess the effect of the hydrogel on ocular tissue. The 
352 biosafety research parameters for structure, function, and inflammation, such as cell proliferation 
353 assays, inflammation detection by slit lamp and aqueous humor tests, visual function assay by 
354 electroretinogram, and anatomical abnormality detection by HE staining and immunostaining, all 
355 indicated that the poly(acrylamide-co-sodium acrylate) hydrogel is qualified as a biosafe 
356 clinical-grade biomaterial for 3D-printed IOLs by systematic investigation and verification both in 
357 vivo and in vitro.
358 The polymers in preformed ophthalmic hydrogels could be semisynthetic or natural. Some of 
359 them can transit from sol to gel conversely triggered by environmental stimuli such as 
360 temperature, pH and ion concentration11,23. As the poly(acrylamide-co-sodium acrylate) hydrogel 
361 was primarily performed by 3D printing, it was harmful to cell proliferation when co-cultured 
362 with LECs. (Figure 1C, D). However, pretreatment of the poly(acrylamide-co-sodium acrylate) 
363 hydrogel with PBS for 9 days robustly reduced the toxic effect to LECS. This result indicated two 
364 points of view: first, the primary poly(acrylamide-co-sodium acrylate) hydrogel could respond to 
365 the cell culture environment conditions and release polymers that inhibit cellular proliferation at a 
366 high concentration; second, adaptation to the extracellular environment is needed and should be 
367 properly investigated and standardized for the safe clinical use of poly(acrylamide-co-sodium 
368 acrylate) hydrogels.
369 When co-cultured with the poly(acrylamide-co-sodium acrylate) hydrogel, both LECs and 
370 ARPE19 cells exhibit contact cell death, while cells located far away from the hydrogel grow 
371 without any abnormalities. Cell migration and proliferation are highly dependent on the 
372 extracellular matrix24. To serve as an ideal environment and matrix, ophthalmic hydrogels must be 
373 composed of gelatin25, alginate26, collagen27, fibrin28, and even molecularly modified biomaterials. 
374 3D-printed IOLs have a high light transparency but may be populated by migratory and 
375 proliferative cells29,30. The contact cell death of the poly(acrylamide-co-sodium acrylate) hydrogel 
376 prevented this possibility of this adverse effect of cell migration and proliferation, which makes it 
377 an ideal transparent biomaterial with the least opacity after IOL implantation.
378 A previous study on the ocular tolerability of a new biomaterial formulation used the “Draize 
379 rabbit eye irritation test,” which is the oldest and most classic test that has been employed to 
380 evaluate potential ocular irritation. However, the Draize test is quite limited by its subjectivity, 
381 poor reproducibility and the need for large numbers of live rabbits31,32. In the current research, we 
382 utilized ELISA to explore the inflammatory factor level of the aqueous humor, and we conducted 
383 electroretinogram analyses to examine the visual function after hydrogel implantation. These 
384 analyses well addressed the shortcomings of the Draize test and provided distinguished data to 
385 gain insight into the effect on ocular inflammation and visual function.
386 Macrophages are a type of immune cell that engulfs and digests debris, foreign substances, and 
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387 microbes 33. They are patrol guards in the microenvironment of all tissues, which are transformed 
388 into active phagocytes by morphology and function and react quickly to various kinds of tissue 
389 damage. There is conclusive evidence in animal models and in situ analysis of human tissues that 
390 the macrophage response is a common feature of various retinal inflammatory diseases34-38. We 
391 found accumulated Iba+ macrophages in the anterior chamber angle and iris of both hydrogel 
392 groups 3 months post-operation. The morphology of Iba+ macrophages in the anterior chamber 
393 angle and iris is ameboid like, suggesting that the phagocytic amoeboid movement of emerging 
394 macrophages is triggered by hydrogel implantation. Most importantly, we found similar results in 
395 the IOL group, which served as a positive biosafe control group, and no corneal opacity, keratic 
396 precipitate, hypopyon, or synechia were observed in the hydrogel or IOL group. 
397 As the implanted IOL will be left in the eye for several years after surgery, there is growing 
398 interest in the use of IOLs as drug reservoirs or as treatment methods for ophthalmic diseases. 
399 Combining 3D printing technology and the biocompatible poly(acrylamide-co-sodium acrylate) 
400 hydrogel as the printing material, as well as a potential material for stimuli-responsive hydrogel 
401 fabrication, we hold the possibility of loading antibiotics, corticosteroids, and NSAIDs in the IOL, 
402 which integrates cataract surgery and postoperative treatments as a one-step procedure39. 
403 Moreover, IOLs can also be incorporated with telescopic lenses, presbyopia-correcting lenses, or 
404 accommodative polyfocal bioanalogical lenses 40,41. These advanced designs could become more 
405 effective and personalized when combined with 3D printing and biocompatible hydrogels. 
406 However, all these IOLs inevitably require rigid biosafety assessments and more clinical studies to 
407 ascertain their safety and effectiveness.
408 In sum, the implantation of the poly(acrylamide-co-sodium acrylate) hydrogel did not disturb 
409 the IOP, blood parameters, electroretinogram or optical structure, indicating that it will not cause 
410 any ocular irritation. However, it is not clear whether this hydrogel lens maintains the nano 
411 smooth surface, which can hopefully to correct visual errors, including the defocusing and 
412 astigmatism caused by traditional IOLs. We will improve the manufacturing process in the future 
413 and test the correction capacity of this new lens in terms of visual quality. Our research provides 
414 insight into the biosafety of poly(acrylamide-co-sodium acrylate) hydrogels in ocular tissue and 
415 demonstrates that poly(acrylamide-co-sodium acrylate) hydrogels are a safe material for 3D 
416 printing of personal IOLs, which hold great potential for future clinical applications.
417
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Abstract
AIM: To assess the biosafety of a poly(acrylamide-co-sodium acrylate) hydrogel as a 3D-printed intraocular lens 
(IOL) material.
METHODS: The biosafety of the poly(acrylamide-co-sodium acrylate) hydrogel was first analyzed in vitro using 
human lens epithelial cells (LECs) and the ARPE19 cell line, and a CCK-8 assay was performed to investigate 
alterations in cell proliferation. A thin film of a poly(acrylamide-co-sodium acrylate) hydrogel and a conventional 
IOL were intraocularly implanted into the eyes of New Zealand white rabbits respectively, and a sham surgery 
served as control group. The anterior segment photographs, intraocular pressure (IOP), blood parameters and 
electroretinograms were recorded. Inflammatory cytokines in the aqueous humor, such as TNF and IL-8, were 
examined by ELISA. Cell apoptosis of the retina was investigated by TUNEL assay, and macrophage activation 
was detected by immunostaining. 
RESULTS: The poly(acrylamide-co-sodium acrylate) hydrogel did not slow cell proliferation when cocultured 
with human LECs or ARPE19 cells. The implantation of a thin film of a 3D-printed IOL composed of the 
poly(acrylamide-co-sodium acrylate) hydrogel did not affect the IOP, blood parameters, electroretinogram or 
optical structure in any of the three experimental groups (n=3 for each group). Both TNF and IL-8 in the 
aqueous humor of the hydrogel group were transiently elevated 1 week post-operation and recovered to normal 
levels at 1 and 3 months post-operation. Iba1+ macrophages in the anterior chamber angle of the hydrogel group 
were increased markedly compared to those of the control group; however, there was no significant difference 
compared to those in the IOL group. 
CONCLUSION: The poly(acrylamide-co-sodium acrylate) hydrogel is a safe material for 3D printing of personal 
IOLs that hold great potential for future clinical applications.
KEYWORDS: Cataract; Biosafety; Lens Epithelial Cells; ARPE19 Cells; Intraocular Lens; 3D Printing; Poly 
Hydrogel; Rabbit
INTRODUCTION
More than 95 million people worldwide have cataracts, which is the leading cause of blindness.1 
Phacoemulsification combined with intraocular lens (IOL) implantation is the most effective way to treat cataract 
so far.2 However, the mass-produced model IOL based on a high-precision machine tool fails to meet the growing 
demands of personalized customization of the human lens, and it is hard to obtain the best postoperative vision.3 
Precision medicine is an inevitable trend in the development of clinical medicine, personalized customization is an 
extremely important component of precision medicine, and personalized IOL customization is an important means 
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to improve the outcome of cataract surgery.
3D printing holds great potential in biomedical engineering research as well as in ophthalmologic 
applications,4-6 which enables cost-effective products and instruments that aid in therapeutic devices, such as 
IOLs, built specifically for individual cataract patients.7 Based on the clinical data, it is possible for us to design a 
personalized IOL suitable for the size of the lens capsule by digital optical modeling, simulating the quality of 
IOL imaging and correcting the wave front aberration.8 Achievement of 3D printing of IOLs is a great challenge, 
and the breakthrough bottleneck lies in the following points: 1) the fabrication of ultrahigh-precision roughness of 
the IOL surface (micro/nano-precision);9 2) the high transparency and UV-blocking ability of materials; 3) the 
flexibility, water richness and micromechanical characteristics of the organic materials; and 4) the biosafety of the 
material for 3D-printed IOLs.10,11 
Additive manufacturing and 3D printing create new approaches for the design and manufacturing of implants, 
such as microstructured eye implants, including multifocal diffractive aspheric IOL.12 We planned to print the IOL 
mold with a new responsive poly(acrylamide-co-sodium acrylate) hydrogel with 3D precise printing technology, 
which aims to provide accurate and personalized IOL products for cataract patients. The gel is a fully diluted 
crosslinking system that has no fluidity in the stable state. The main component of the gel is liquid by weight. 
However, due to the 3D crosslinking network, the structural integrity of the hydrogel network will not be 
dissolved due to the high hydrophilicity. Hydrogels are highly absorbent and light permeable (containing more 
than 90% water). Due to its high water content, the hydrogel also has a very similar flexibility to natural tissue, 
which makes it an ideal 3D printing material for making personalized IOLs. However, as responsive smart 
materials, hydrogels can encapsulate chemical compounds such as glucose, which are released by the stimulation 
of external factors, such as changes in pH. Thus, whether a poly(acrylamide-co-sodium acrylate) hydrogel is toxic 
to ocular tissue needs to be deliberately considered. Nevertheless, the issue of the biosafety of 
poly(acrylamide-co-sodium acrylate) hydrogels is unclear so far.
Here, we utilized a poly(acrylamide-co-sodium acrylate) hydrogel to create a thin film in order to investigate its 
biosafety after intraocular implantation. It was demonstrated in vivo that IOP, ERGs and inflammatory factors in 
the aqueous humor exhibited no significant difference after poly(acrylamide-co-sodium acrylate) hydrogel 
implantation. Moreover, similar results could be verified by experiments in vitro. Taken together, the results 
indicate that the poly(acrylamide-co-sodium acrylate) hydrogel does not harm the rabbit ocular tissue and causes 




All experiments were performed on New Zealand white rabbits provided by the Experimental Animal Centre of 
Southwest Hospital, Army Medical University. The New Zealand white rabbits were all raised in the Animal Care 
Centre of the Army Medical University and maintained with free access to water and food under a 12-h light/dark 
cycle. All animal experimental procedures were formally approved by the Institutional Review Board of the Army 
Medical University.
Preparation of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Thin Film
The hydrogel solution was prepared according to the following formula: 17.5% N-isopropylacrylamide; 12.5% 
sodium acrylate; 1.5% N,N’-methylenebisacrylamide; N,N,N’,N’-tetramethylethylenediamine; 10% ammonium 
persulfate, H20. The solution was added to one of the molds and immediately joined with another mold. Then, the 
two pieces of mold were clamped together. After 30~60 minutes, after the gel was solidified, and the two molds 
were removed. The formed hydrogel crystals were transferred to phosphate buffered saline (PBS) for preservation.
Intraocular Implantation of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Thin Film into New 
Zealand White Rabbit Eyes
The New Zealand white rabbits were divided into three groups based on implants: the 
poly(acrylamide-co-sodium acrylate) hydrogel thin film as the hydrogel group, the conventional IOL as the IOL 
group, and the sham surgery as the control group (n=3 for each group). Animals were anesthetized with 3% 
pentobarbital sodium 1 ml/kg through the ear-rim auricular vein; the left eye was selected as the operative eye. 
Before the operation, tropicamide eye drops (Santen) were used for mydriasis. The eyelid was opened with an eye 
speculum, and the conjunctival sac was soaked with 5% povidone iodine for 90 seconds and then rinsed with 
saline. A 3.0 mm width transparent corneal incision was made at the 12 o’clock position, a 1.0 mm width 
auxiliary corneal incision was made at the 9 o’clock position, and sodium hyaluronate (SINGCLEAN) was 
injected into the anterior chamber. For the control group, the incision was sutured directly with 10-0 
polypropylene. For the hydrogel group and IOL group, we performed capsulorhexis, water separation, and 
phacoemulsification of the lens nucleus (Laureate, Alcon, USA), cleared the lens cortex with I/A, and injected the 
poly(acrylamide-co-sodium acrylate) hydrogel thin film (5 mm×5 mm) or IOL (860 UV, acrylic intraocular lenses 
as a positive control of biosafety). The 12 o’clock incision was sutured with 10-0 nylon suture, balanced salt 
solution (BSS) was injected to form the anterior chamber capacity, and tobramycin dexamethasone eye ointment 
(Alcon, USA) was applied to the eyes after the operation. Intraocular pressures (IOP) was measured by a 
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noncontact tonometer at 1 day, 1 week, 1 month, and 3 months post-operation.
Euthanasia and Histopathology
Three months after implantation, the New Zealand white rabbits were euthanized with pentobarbital sodium 
(400 mg/kg) administered intravenously. Afterwards, each eye containing the implant was taken from each rabbit 
for histological examination. Specimens were fixed in 4% paraformaldehyde for at least 24 hours and dehydrated 
in 30% sucrose for at least 24 hours, followed by embedding with Tissue-Tek O.C.T. Compound (Sakura Finetek 
USA, Inc., Torrance, CA 90501, USA). All tissue pieces were cut into 2–4 μm thick tissue sections (Leica 
CM1900UV cryostat). Then, all sections were routinely stained with hematoxylin-eosin (HE) and examined under 
a light microscope (OLYMPUS DP71; Olympus Europa SE & Co. KG, Hamburg, Germany) to assess fibroblast 
proliferation and anatomical abnormalities.
Cell Culture
Human lens epithelial cells (LECs) were expanded from lens explants, which were provided by the Southwest 
Hospital Eye Bank. Briefly, the lens was washed in cold PBS containing 50 U mL-1 penicillin and 100 μg mL-1 
streptomycin, cut into 5 mm×5 mm small pieces and seeded onto human vitronectin (Gibco, Thermo Fisher, USA) 
precoated plates, and the explants were left for attachment. The second day, LECs were cultured in conditioned 
medium consisting of DMEM/F12 (HyClone), 10% FBS (Gibco), insulin-transferrin sodium selenite (1 μg mL-1, 
Gibco), penicillin (100 U mL-1) and streptomycin (100 μg mL-1, HyClone). As cells reached subconfluence, they 
were gently passaged at 1:6 to expand. The ARPE19 cell line was cultured according to the same procedures and 
conditions described above. The cells were co-cultured with the poly(acrylamide-co-sodium acrylate) hydrogel 
thin film (5 mm×5 mm) or PBS as control.
Immunostaining to Identify LECs
Immunostaining was routinely performed as previously described.13 Sections were incubated for 15 minutes 
with PBS, and sections were further incubated with PBS containing 0.1% (vol/vol) Triton X-100 for 15 minutes 
and further blocked with 1% (wt/vol) bovine serum albumin (BSA) in PBS at room temperature. The following 
primary antibodies were incubated at 4℃ overnight: Pax6 (1:500, Abcam), Sox2 (1:400, Abcam), αA-crystallin 
(1:200, Santa Cruz), α-SMA (1:400, Abcam), and Iba1 (1:500, Wako).
TUNEL Staining to Analyze the Apoptotic Cells and Immuno Cells in the Eyes Of Rabbits
Using the TUNEL Assay Kit (Abcam) as previously described14, the secondary antibodies included the goat 
anti-mouse Alexa Fluor 488 and goat anti-mouse Alexa Fluor 594 (Invitrogen). DAPI (1:10, Beyotime) was 
incubated for 8-10 minutes at 20℃ to counterstain nuclei, followed by cover-slipping with antifade mounting 
medium (Beyotime).
CCK-8 Assay to Analyze the Proliferation of LECs and APRE19 Cells
The cytotoxicity of the poly(acrylamide-co-sodium acrylate) hydrogel was measured using the Cell Counting 
Kit-8 (CCK-8) assay according to a previously published protocol.15 Absorbance at wavelengths of 450 and 650 
nm was collected using a microplate reader (Varioskan Flash, Thermo Fisher, USA).
ELISA Assay to Analyze Cytokines
The aqueous humor was extracted with a 30G sterile needle syringe at the 9 o’clock position of the limbus at 1 
week, 1 month, and 3 months post-operation. ELISAs to detect IL-8 and TNF (cloud-clone corp.) were performed 
as previously reported.16 The absorbance of each well was read at 450 nm and 550 nm. The 550 nm values were 
subtracted from the 450 nm values to correct for optical imperfections in the microplate. 
Electroretinogram Recording to Assess The Visual Function of Rabbits
Scotopic flash electroretinogram recording was performed at 3 months post-operation as described previously.17 
Briefly, after 12-h dark adaptation, the rabbits were carefully anesthetized with 3% pentobarbital sodium (1 
ml/kg). The pupils were dilated with 1% tropicamide. The body temperature was maintained at 37 °C with a 
heating pad to prevent hypothermia. Active gold electrodes were placed onto cornea serving as the recording 
electrodes. The reference and ground electrodes were placed subcutaneously in the mid-frontal areas of the head 
and back, respectively. We performed light stimulation at densities of −2.5, −0.5, −0.02, and 0.5 log (cd*s/m2) for 
New Zealand white rabbits and 0.5 log (cd*s/m2) for rabbits. The amplitudes and peak times of the a-waves and 
b-waves were recorded and processed through a RETI-Port device (Roland Consult). All experimental procedures 
were performed in a dark room under dim red safety light. 
Microscopy, Image Acquisition, And Processing
All confocal images were collected by a Zeiss LSM880. Immunostaining data were all processed in ImageJ and 
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Data are shown as the means ± S.D. All statistical tests were performed by PRISM (GraphPad). Statistical 
significance was detected by Student’s t test (parametric). A P-value <0.05 was considered statistically 
significant. 
RESULTS
Synthesis of the Poly(acrylamide-co-sodium acrylate) Hydrogel
The new responsive poly(acrylamide-co-sodium acrylate) hydrogel was made from our modified formula as 
described in the materials and methods section. To produce patterned morphology and structure, a precise 
3D-printed IOL mold was injected into the new responsive poly(acrylamide-co-sodium acrylate) hydrogel (Figure 
1A). To better adapt for implantation into rabbit eyes, a thin film-like poly(acrylamide-co-sodium acrylate) 
hydrogel was made (Figure 1B). As a fresh hydrogel often remains unstable and releases small molecular 
chemical compounds such as glucose, to achieve a stable state of the poly(acrylamide-co-sodium acrylate) 
hydrogel, we pretreated the hydrogel with PBS and examined its optimal condition to reduce the influence on 
LECs. We found that after 9 days of pretreatment with PBS, the poly(acrylamide-co-sodium acrylate) hydrogel 
did not affect the survival or proliferation of LECs (Figure 1C, D).
Figure 1 Synthesis of the poly(acrylamide-co-sodium acrylate) hydrogel thin film
A: A precise 3D-printed IOL mold was injected into the new responsive poly(acrylamide-co-sodium acrylate) 
hydrogel to produce a patterned morphology and structure; B: Image of the poly(acrylamide-co-sodium acrylate) 
hydrogel thin film; C: Trypan blue staining of LECs co-cocultured with the poly(acrylamide-co-sodium acrylate) 
hydrogel at 0, 3, 6, and 9 days of the PBS wash; D: CCK8 assay of LECs co-cocultured with the 
poly(acrylamide-co-sodium acrylate) hydrogel at 0, 3, 6, and 9 days of the PBS wash; Data are shown as the 
mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p < 0.005
Effect of the Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel on LECs and ARPE19 Cells in Vitro
To investigate whether the poly(acrylamide-co-sodium acrylate) hydrogel disturbs cell viability, we cocultured 
the poly(acrylamide-co-sodium acrylate) hydrogel with LECs and ARPE19 cells. The cultured cells positively 
expressed LEC markers, such as PAX6 and SOX2, and synthesized the specific -A crystallin and negatively 
expressed the fibroblast cell marker -SMA, which identified the LECs (Figure 2A~F). When LECs were 
cocultured with the poly(acrylamide-co-sodium acrylate) hydrogel, cell apoptosis emerged only at the adjacent 
area around the hydrogel (Figure 2G, H). A similar result could be obtained when it cocultured with ARPE19 
cells.
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Figure 2 Coculture of poly(acrylamide-co-sodium acrylate) hydrogel thin films with LECs or ARPE19 cells 
A~F: Immunostaining of LECs showed that LECs were positively stained for the lens epithelial cell markers 
PAX6 (A, B), SOX2 (C), and α-A crystallin (D, E) and negatively stained for the fibroblast cell marker α-SMA 
(F); D~H: Bright field images of LECs co-cultured with (H) or without (G) the poly(acrylamide-co-sodium 
acrylate) hydrogel. Cells adjacent to the hydrogel were unable to attach to the matrix and ultimately underwent 
apoptosis (red arrow); I~J: Bright field images of ARPE19 cells co-cultured with the poly(acrylamide-co-sodium 
acrylate) hydrogel (I). The magnified image (J, white dashed area in I) shows that a minority of adjacent cells 
underwent cell apoptosis (red arrow), whereas the distal cells stayed in a normal proliferative state. Scale bar, 50 
μm (A~F), 100 μm (G~J).
Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel into The Anterior Chamber of New 
Zealand White Rabbits Does Not Induce Endophthalmitis
   To further evaluate the biosafety of poly(acrylamide-co-sodium acrylate) hydrogels, we performed intraocular 
implantation in New Zealand white rabbits. Slit-lamp imaging at 1 week post-operation indicated corrected 
location of the hydrogel at the anterior chamber (Figure 3A~C). No significant corneal opacification, keratic 
precipitate, hypopyon, or synechia was observed at 1 month post-operation among all the groups (Figure 3D~F). 
Moreover, no anatomic abnormalities were observed at 3 months post-operation among all the groups (Figure 
3G~I). In addition, the alteration of IOP after hydrogel implantation was not statistically significant (Figure 4A). 
To further investigate the effect of poly(acrylamide-co-sodium acrylate) hydrogel implantation on the intraocular 
inflammatory reaction, we performed ELISA to examine the key inflammatory factors IL-8 and TNF-α. ELISA of 
the aqueous humor showed that IL-8 (Figure 4B) and TNA- (Figure 4C) of both the hydrogel and IOL groups 
were elevated at the first week post-operation, but that of the hydrogel group stayed consistent with that of the 
control group at 1 month and 3 months post-operation. In sum, implantation of the poly(acrylamide-co-sodium 
acrylate) hydrogel did not induce any endophthalmitis in the New Zealand white rabbit eyes. 
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Figure 3 Implantation of poly(acrylamide-co-sodium acrylate) hydrogel thin film into the anterior chamber 
of New Zealand white rabbits does not induce endophthalmitis
A~C: Slit lamp images of the control group (A), hydrogel group (B) and IOL group (C) at 1 week post-operation 
showed successful implantation and correct location of the implants; D~F: Slit lamp images of the control group 
(D), hydrogel group (E) and IOL group (F) at 1 month post-operation showed no significant corneal opacification, 
keratic precipitate or endophthalmitis; G~I: Slit lamp images of the control group (G), hydrogel group (H) and 
IOL group (I) at 3 months post-operation showed no significant corneal opacification, keratic precipitate or 
endophthalmitis. Week post-operation (WPO); Month post-operation (MPO); Yellow arrow: Hydrogel.
Figure 4 Effects of poly(acrylamide-co-sodium acrylate) hydrogel implantation on the IOP and 
inflammatory factors in the aqueous humor
A: The IOP recordings revealed showed no significant differences among the control, hydrogel and IOL groups; 
B~C: ELISA of inflammatory factors such as IL-8 (B) and TNF-α (C) in the aqueous humor of the control, 
hydrogel and IOL groups; Data are shown as the mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p 
< 0.005; n.s. no significance.
Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Does Not Impair Visual Function 
   Visual function may be well reflected by visual electrophysiology examinations, such as electroretinography 
(ERG). To further investigate the effect of poly(acrylamide-co-sodium acrylate) hydrogel implantation on visual 
function, we conducted flash-ERG examinations of the control, hydrogel, and IOL groups. The amplitude of the 
a-wave of rod, cone and combined rod-cone (Max) ERG 3 months after hydrogel implantation was not 
significantly altered, nor was the peak time of the wave (Figure 5A, B). Similarly, both the amplitude and peak 
time of the b-wave of rod, cone and combined rod-cone (Max) ERG 3 months after hydrogel implantation were 
also not significantly altered (Figure 5C, D). These results indicated normal function of photoreceptor cells and 
bipolar cells in the hydrogel groups 3 months post-operation. Moreover, we analyzed the characteristics of the 
Ops wave and light-adapted 30 Hz flicker. Consistent with the results above, the implantation of hydrogel did not 
affect the amplitude of the Ops wave and light-adapted 30 Hz flicker, as well as its peak time (Figure 5E~G), 
indicating an intact and well-functioning inner retina and cone system.
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Figure 5 Flash-ERGs of New Zealand white rabbits at 3 months post-implantation
A~B: Statistical analysis of the amplitudes (A) and peak time (B) of fERG a-waves at 0.5 log(cd*s/m2) in the 
three groups at 3 months post-operation; C~D: Statistical analysis of the amplitudes (C) and peak time (D) of 
fERG b-waves at 0.5 log(cd*s/m2) in the three groups at 3 months post-operation; E~G: Statistical analysis of the 
Ops wave amplitude (E) at 3.0 log (cd*s/m2) in the three groups at 3 months post-operation; F~G: Statistical 
analysis of the light-adapted 30 Hz flicker amplitude (F) and peak time (G) at 3.0 log(cd*s/m2) in the three groups 
at 3 months post-operation; Data are shown as the mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; 
***p < 0.005; n.s. no significance.
Implantation of Poly(Acrylamide-Co-Sodium Acrylate) Hydrogel Does Not Damage Ocular Histology
   Novel biomaterials are often toxic to the ocular tissue and cause severe abnormalities in histology. To evaluate 
the effect of poly(acrylamide-co-sodium acrylate) hydrogel implantation on the ocular histology, we first 
performed HE staining of New Zealand White Rabbit eyes after 3 months of surgery. This result indicated that the 
hydrogel group maintained its normal histological characteristics, such as cell connections and layered lamination, 
as well as did the IOL group, all compared with the control group (Figure 6A, B, C). The TUNEL assay revealed 
that no cellular apoptosis emerged at the cornea, anterior chamber angle (ACA), or retina in any of the three 
groups, confirming the nontoxic character of the poly(acrylamide-co-sodium acrylate) hydrogel (Figure 7J~R). 
Moreover, IBA1+ macrophage cells did not accumulate in the cornea or retina except for the ACA in the hydrogel 
and IOL groups 3 months post-implantation (Figure 7A~I). The recruitment of macrophages at the ACA may 
represent the immune response caused by the hydrogel or IOL implants, which triggered the phagocytic activation 
of macrophages.
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Figure 6 The poly(acrylamide-co-sodium acrylate) hydrogel does not cause histological alteration 3 months 
post-implantation
A: HE staining of New Zealand White Rabbit eyes showed the detailed histological identity of the cornea, anterior 
chamber angle, and retina in the control group; B: HE staining of New Zealand White Rabbit eyes showed the 
detailed histological identity of the cornea, anterior chamber angle, and retina in the hydrogel group. The cell 
connectivity and layered lamination were normal compared with those of the control group, even though the 
cornea was ruptured due to the limitations of the HE staining procedure; C: HE staining of New Zealand White 
Rabbit eyes showed the detailed histological identity of the cornea, anterior chamber angle, and retina in the IOL 
group. Scale bar, 100 μm.
Page 31 of 35
www.ijo.cn





























































Figure 7 Macrophage activation and cell apoptosis of New Zealand white rabbit eyes 3 months after 
poly(acrylamide-co-sodium acrylate) hydrogel implantation
A~I: Immunostaining of Iba1 in New Zealand white rabbit eyes at 3 months post-implantation showed Iba1+ 
macrophage augmentation at the cornea (A~C), ACA (D~F) and retina (G~I) in the control group (A, D, G), the 
hydrogel group (G, E, H), and the IOL group (C,F,I); J~R: TUNEL assay of New Zealand White Rabbit eyes at 3 
months post-implantation showed TUNEL+ apoptotic cell accumulation at the cornea (J~L), ACA (M~O) and 
retina (P~R) in the control group (J, M, P), the hydrogel group (K, N, Q), and the IOL group (L, O, R); S: 
Statistical analysis of Iba+ macrophages in the cornea, ANA, and retina in all three groups. Scale bar, 100 μm. 
Data are shown as the mean±s.d. Independent sample t test. *p < 0.05, **p < 0.01; ***p < 0.005; n.s. no 
significance.
DISCUSSION
The eye exerts a unique ocular morphology, and all ocular organic architectures are susceptible to a number of 
diseases that may require treatment via different modalities, such as sustained drug delivery and artificial biotissue 
substitution.18 In the past century, hydrogels have been used in various applications as effective materials. The 
unique network structure of a hydrogel makes it highly hydrophilic and biocompatible, and it exhibits soft 
physical properties similarly to living tissue, which makes it an ideal and potential biomaterial for ophthalmic 
applications such as intraocular pumps, injections and implants, reducing comorbidities caused by glaucoma, 
cataracts, and diabetic retinopathies.19 3D printing allows the creation of objects with complex three-dimensional 
geometries and photologies from a computer-aided design and printed biomaterials to tissue analog structures 
without any change in their mechanical or biological properties.20,21 However, given the nature of the polymers in 
hydrogel formulations and the materials used in the preparation of ophthalmic gels, it is paramount that any new 
hydrogel formulation intended for ocular application should be inevitably investigated for potential 
toxicity/adverse effects on ocular tissues. In this report, we generated a poly(acrylamide-co-sodium acrylate) 
hydrogel as a thin film and found that the newly formed hydrogel needs 9 days of pretreatment with PBS to 
stabilize its structure, reflecting the stimuli-controlled phase transition and small molecule release characteristics 
of stimulus-responsive hydrogels22. Second, we performed coculture experiments in vitro and implantation 
experiments in vivo to assess the effect of the hydrogel on ocular tissue. The biosafety research parameters for 
structure, function, and inflammation, such as cell proliferation assays, inflammation detection by slit lamp and 
aqueous humor tests, visual function assay by electroretinogram, and anatomical abnormality detection by HE 
staining and immunostaining, all indicated that the poly(acrylamide-co-sodium acrylate) hydrogel is qualified as a 
biosafe clinical-grade biomaterial for 3D-printed IOLs by systematic investigation and verification both in vivo 
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The polymers in preformed ophthalmic hydrogels could be semisynthetic or natural. Some of them can transit 
from sol to gel conversely triggered by environmental stimuli such as temperature, pH and ion concentration11,23. 
As the poly(acrylamide-co-sodium acrylate) hydrogel was primarily performed by 3D printing, it was harmful to 
cell proliferation when co-cultured with LECs. (Figure 1C, D). However, pretreatment of the 
poly(acrylamide-co-sodium acrylate) hydrogel with PBS for 9 days robustly reduced the toxic effect to LECS. 
This result indicated two points of view: first, the primary poly(acrylamide-co-sodium acrylate) hydrogel could 
respond to the cell culture environment conditions and release polymers that inhibit cellular proliferation at a high 
concentration; second, adaptation to the extracellular environment is needed and should be properly investigated 
and standardized for the safe clinical use of poly(acrylamide-co-sodium acrylate) hydrogels.
When co-cultured with the poly(acrylamide-co-sodium acrylate) hydrogel, both LECs and ARPE19 cells 
exhibit contact cell death, while cells located far away from the hydrogel grow without any abnormalities. Cell 
migration and proliferation are highly dependent on the extracellular matrix24. To serve as an ideal environment 
and matrix, ophthalmic hydrogels must be composed of gelatin25, alginate26, collagen27, fibrin28, and even 
molecularly modified biomaterials. 3D-printed IOLs have a high light transparency but may be populated by 
migratory and proliferative cells29,30. The contact cell death of the poly(acrylamide-co-sodium acrylate) hydrogel 
prevented this possibility of this adverse effect of cell migration and proliferation, which makes it an ideal 
transparent biomaterial with the least opacity after IOL implantation.
A previous study on the ocular tolerability of a new biomaterial formulation used the “Draize rabbit eye 
irritation test,” which is the oldest and most classic test that has been employed to evaluate potential ocular 
irritation. However, the Draize test is quite limited by its subjectivity, poor reproducibility and the need for large 
numbers of live rabbits31,32. In the current research, we utilized ELISA to explore the inflammatory factor level of 
the aqueous humor, and we conducted electroretinogram analyses to examine the visual function after hydrogel 
implantation. These analyses well addressed the shortcomings of the Draize test and provided distinguished data 
to gain insight into the effect on ocular inflammation and visual function.
Macrophages are a type of immune cell that engulfs and digests debris, foreign substances, and microbes 33. 
They are patrol guards in the microenvironment of all tissues, which are transformed into active phagocytes by 
morphology and function and react quickly to various kinds of tissue damage. There is conclusive evidence in 
animal models and in situ analysis of human tissues that the macrophage response is a common feature of various 
retinal inflammatory diseases34-38. We found accumulated Iba+ macrophages in the anterior chamber angle and iris 
of both hydrogel groups 3 months post-operation. The morphology of Iba+ macrophages in the anterior chamber 
angle and iris is ameboid like, suggesting that the phagocytic amoeboid movement of emerging macrophages is 
triggered by hydrogel implantation. Most importantly, we found similar results in the IOL group, which served as 
a positive biosafe control group, and no corneal opacity, keratic precipitate, hypopyon, or synechia were observed 
in the hydrogel or IOL group. 
As the implanted IOL will be left in the eye for several years after surgery, there is growing interest in the use 
of IOLs as drug reservoirs or as treatment methods for ophthalmic diseases. Combining 3D printing technology 
and the biocompatible poly(acrylamide-co-sodium acrylate) hydrogel as the printing material, as well as a 
potential material for stimuli-responsive hydrogel fabrication, we hold the possibility of loading antibiotics, 
corticosteroids, and NSAIDs in the IOL, which integrates cataract surgery and postoperative treatments as a 
one-step procedure39. Moreover, IOLs can also be incorporated with telescopic lenses, presbyopia-correcting 
lenses, or accommodative polyfocal bioanalogical lenses 40,41. These advanced designs could become more 
effective and personalized when combined with 3D printing and biocompatible hydrogels. However, all these 
IOLs inevitably require rigid biosafety assessments and more clinical studies to ascertain their safety and 
effectiveness.
In sum, the implantation of the poly(acrylamide-co-sodium acrylate) hydrogel did not disturb the IOP, blood 
parameters, electroretinogram or optical structure, indicating that it will not cause any ocular irritation. However, 
it is not clear whether this hydrogel lens maintains the nano smooth surface, which can hopefully to correct visual 
errors, including the defocusing and astigmatism caused by traditional IOLs. We will improve the manufacturing 
process in the future and test the correction capacity of this new lens in terms of visual quality. Our research 
provides insight into the biosafety of poly(acrylamide-co-sodium acrylate) hydrogels in ocular tissue and 
demonstrates that poly(acrylamide-co-sodium acrylate) hydrogels are a safe material for 3D printing of personal 
IOLs, which hold great potential for future clinical applications.
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